13 insiders reported 62 Form 4 transactions for HERON THERAPEUTICS, INC. /DE/ (HRTX) over the past 18 months (most recent 2026-06-17). Recent activity: Duarte Ira (EVP, Chief Financial Officer) Sell 3,555 shares, Duarte Ira (EVP, Chief Financial Officer) Buy 12,500 shares, Forbes William P (EVP, Chief Development Officer) Buy 12,500 shares, Hensley Mark Earl (Chief Operating Officer) Buy 125,000 shares, Duarte Ira (EVP, Chief Financial Officer) Buy 3,874 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-17 | Duarte Ira | EVP, Chief Financial Officer | Sell | 3,555 | $1,351 |
| 2026-06-17 | Duarte Ira | EVP, Chief Financial Officer | Buy | 12,500 | $0 |
| 2026-06-08 | Forbes William P | EVP, Chief Development Officer | Buy | 12,500 | $0 |
| 2026-05-07 | Hensley Mark Earl | Chief Operating Officer | Buy | 125,000 | $0 |
| 2026-04-21 | Duarte Ira | EVP, Chief Financial Officer | Buy | 3,874 | $0 |
| 2026-04-21 | Forbes William P | EVP, Chief Development Officer | Buy | 3,874 | $0 |
| 2026-04-21 | Collard Craig A | Chief Executive Officer | Buy | 13,797 | $0 |
| 2026-04-06 | Collard Craig A | Chief Executive Officer | Buy | 62,500 | $0 |
| 2026-02-03 | Dissanaike Sharmila | Director | Buy | 53,960 | $0 |
| 2026-02-03 | Forbes William P | EVP, Chief Development Officer | Buy | 11,695 | $0 |
| 2026-02-03 | Cusack Thomas | Director | Buy | 53,960 | $0 |
| 2026-02-03 | Morgan Adam | Director | Buy | 53,960 | $0 |
| 2026-02-03 | Johnson Craig A | Director | Buy | 53,960 | $0 |
| 2026-02-03 | Duarte Ira | EVP, Chief Financial Officer | Buy | 11,695 | $0 |
| 2026-02-03 | Christian Waage | Director | Buy | 53,960 | $0 |
| 2026-02-03 | Kaseta Michael | Director | Buy | 53,960 | $0 |
| 2026-02-03 | Collard Craig A | Chief Executive Officer | Buy | 34,789 | $0 |
| 2026-01-20 | Collard Craig A | Chief Executive Officer | Buy | 13,797 | $0 |
| 2026-01-20 | Forbes William P | EVP, Chief Development Officer | Buy | 3,875 | $0 |
| 2026-01-20 | Duarte Ira | EVP, Chief Financial Officer | Buy | 3,875 | $0 |
| 2025-11-12 | Cusack Thomas | Director | Buy | 37,879 | $0 |
| 2025-11-04 | Collard Craig A | Chief Executive Officer | Buy | 34,789 | $0 |
| 2025-11-04 | Duarte Ira | EVP, Chief Financial Officer | Buy | 11,694 | $0 |
| 2025-11-04 | Forbes William P | EVP, Chief Development Officer | Buy | 11,694 | $0 |
| 2025-10-21 | Duarte Ira | EVP, Chief Financial Officer | Buy | 3,874 | $0 |
Source: SEC Form 4 filings · as of 2026-06-17